WHO: TB killed 1.3m people last year
Tuberculosis claimed 1.3 million lives last year with drug-resistant forms of the infectious disease — the deadliest after AIDS — a huge global concern, the WHO warned yesterday.
Worldwide efforts to rein in the killer airborne disease helped drive the toll down 100,000 from the previous year, the World Health Organization said in its annual report on the fight against TB. But the toll remains the world’s second-highest for an infectious disease, after HIV/AIDS.
An estimated 8.6 million people caught tuberculosis in 2012, with India alone accounting for 26 percent of cases, and China, 12 percent.
According to the WHO, close to one-third of TB cases were in Southeast Asia, just over a quarter in Africa and around one-fifth on the Western Pacific region.
Looking at the longer-term picture, the number of infections fell by nearly half from 1990 to 2012.
But experts reckon only two-thirds of last year’s 8.6 million new cases were actually diagnosed, leaving an estimated 3 million people unaware they had the disease. Those most at risk are typically among the worst-off groups of the population.
“To find the 3 million TB cases means we need to reach beyond the current health services, we need to look at where these cases are,” WHO expert Karin Meyer said.
“These are often vulnerable populations, displaced populations, migrant population, quite difficult to reach,” she added.
Global health experts also warned of the growing threat posed by a strain of TB that resists drugs used to fight the classic form. Multidrug-resistant TB, or MDR-TB, which emerged due to erratic treatment of the regular strain or excessive use of anti-TB medication, claimed 170,000 lives last year, the WHO said.
Some 94,000 people were diagnosed with MDR-TB last year, twice the figure in 2011.But the true number of cases is thought to be around five times higher, the WHO said.
The highest density of MDR-TB cases is found in Eastern Europe and Central Asia. Those are places where TB programs have long been in place, but where failings in health services have allowed drug-resistance to build up, officials said.
In contrast, Africa has seen lower levels of MDR-TB, in part because of weaker access to standard TB treatment in the past.
Other countries hit hard by MDR-TB include China and India.
“The unmet demand for a full-scale and quality response to multidrug-resistant tuberculosis is a real public health crisis,” said Mario Raviglione, head of the WHO’s TB program.
The standard drugs used to treat TB are isoniazid and rifampicin. Vaccines are in development, but are not expected to hit the market before 2025, the WHO said.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.